Why HUN Stock surged +7.47% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, HUN scores 40 out of 100, a letter grade of D-, with the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." Across the five pillars: Fundamental Cash Engine scores 10 of 20 (ROIC -2.6%; FCF yield 7.37%), Whale 13F Flow scores 6 of 20 (institutional accumulation and options positioning), Insider Conviction scores 9 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit scores 7 of 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet scores 8 of 20 (Altman Z 1.42; Piotroski F 5/9; Debt/Equity 0.6).

For a prospective investor, the scoring points to weakness across every pillar, with the institutional-flow and macro-fit pillars scoring lowest relative to their weight. The FCF yield of 7.37% sits alongside a negative ROIC of -2.6%, which indicates that cash generation is not translating into returns on invested capital in the period reported. The Altman Z of 1.42 and Piotroski F of 5/9 describe a balance sheet and fundamental profile the rating treats as vulnerable. A possible upside driver would be a sustained improvement in operating profitability; the source data does not establish that such an improvement is underway. Valuation tradeoffs are visible in the dividend yield of 9.28% alongside negative operating and net margins, a combination the rating frames as a sustainability question rather than a support.

Huntsman Corporation (HUN) is a NYSE-listed issuer classified in the Materials sector and Major Chemicals industry, per the profile section. The source data does not describe its products, customers, or revenue model beyond this classification. Market capitalization is listed at $1.6B in the profile. Gross margin of 13.2% and operating margin of -2.3% are reported in market data, but the source data does not specify the product lines that generate them.

Per the SEC financials, revenue declined from $6111.0M in FY 2023 to $5683.0M in FY 2025, and operating income moved from $84.0M to $-131.0M over the same span. Net margin is reported as -5% and operating margin as -2.3% in market data. ROIC is -2.6% per market data. Per the Roarable RQD rating, the Altman Z-Score is 1.42 and the Piotroski F-Score is 5/9, with Debt/Equity of 0.6; debt rose from $1510.0M in FY 2024 to $1658.0M in FY 2025 while cash rose from $340.0M to $429.0M.

The news wire contains six items, all relating to HUN:

• Estimates report (TradingView, YELLOW, MARKET WIRE): "Huntsman Corporation Estimates" — the item's summary is generic and does not state specific estimates.
• Sell-side rating (MarketBeat, YELLOW, MARKET WIRE): Headline states the stock is now rated "Hold" by sell-side analysts.
• Price target cut (TradingView, RED, RISK WATCH): Headline states the 12-month price target was cut to $10.94, implying 27% upside.
• Barclays upgrade (MarketBeat, GREEN, CATALYST): Headline states the stock rating was upgraded by Barclays.
• Price action (siam.in source, YELLOW, MARKET WIRE): Headline states HUN edged lower to $8.57 amid mixed chemical-sector sentiment and references inverse ETF flow.
• Earnings-season list (TradingView, GREEN, CATALYST): Headline references four chemical stocks set to beat earnings; HUN is the related symbol.

The butterfly supply-chain graph reports sector Materials, industry Major Chemicals, supply chain "NONE," with no butterfly links and no proprietary signals.

• What are the specific product lines and end markets that generate HUN's revenue, given the source data provides only sector and industry classification?
• What drove the change from positive FY 2023 net income of $101.0M to losses of $-189.0M and $-284.0M in FY 2024 and FY 2025?
• What are the EPS and P/E figures, which the source data lists as unavailable or N/A for every period?
• What is the composition of the $1658.0M FY 2025 debt, including maturity schedule and interest cost?
• Which analysts issued the cited "Hold" and Barclays ratings, and what are the underlying estimates?